Five species, two drugs, one pill
An affordable and efficient tool to control infection
Our approach at STOP2030 is to combine two existing drugs into a single tablet that allows a more efficient and affordable treatment of helminthic infections.These two compounds are albendazole and ivermectin, both anthelmintics already licensed and widely-used around the world. Their mechanisms of action are different, resulting in a broader efficacy and minimising the risk of resistances. This combination has been proved safe and effective by our previous clinical trials, and is in the last stages of development before regulatory approval.